Baseline characteristics

Bortezomib, Cladribine, and Rituximab in Treating Patients With Advanced Mantle Cell Lymphoma or Indolent Lymphoma · Source last updated 2019-12-30

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      24

   units

   Participants

groups

1. description

   * Rituximab 375 mg/m2 IV day1 * Cladribine 4 mg/m2 IV over 2 hours days 1-5 * Bortezomib 1.3 mg/m2 IV days 1 and 4 * Repeat every 28 days for a maximum of 6 cycles rituximab: 375 mg/m2 IV Day 1. Repeat every 28 days for a maximum of 6 cycles. bortezomib: 1.3 mg/m2 IV Days 1 and 4. Repeat every 28 days for a maximum of 6 cycles. cladribine: 4 mg/m2 IV over 2 hours Days 1-5. Repeat every 28 days for a maximum of 6 cycles.

   id

   BG000

   title

   VCR (Velcade, Cladribine and Rituximab)

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            spread

            11.4

            value

            66.5

   dispersion Type

   STANDARD_DEVIATION

   param Type

   MEDIAN

   title

   Age, Continuous

   unit Of Measure

   years

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            6

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            18

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

3. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            2

         title

         Hispanic or Latino

      2. measurements

         1. group Id

            BG000

            value

            22

         title

         Not Hispanic or Latino

      3. measurements

         1. group Id

            BG000

            value

            0

         title

         Unknown or Not Reported

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Ethnicity (NIH/OMB)

   unit Of Measure

   Participants

4. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            24

      title

      United States

   param Type

   NUMBER

   title

   Region of Enrollment

   unit Of Measure

   participants

5. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            11

         title

         Mantle-cell lymphoma

      2. measurements

         1. group Id

            BG000

            value

            5

         title

         Follicular lymphoma

      3. measurements

         1. group Id

            BG000

            value

            4

         title

         Marginal zone lymphoma

      4. measurements

         1. group Id

            BG000

            value

            3

         title

         Lymphoplasmacytic lymphoma

      5. measurements

         1. group Id

            BG000

            value

            1

         title

         Small lymphocytic lymphoma

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Histology

   unit Of Measure

   Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice